PIM
ANAB icon

Partner Investment Management’s AnaptysBio ANAB Stock Holding History

Partner Investment Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-6,731
Closed -$429K – 93
2018
Q4 		$429K Sell
6,731
-5,092
-43% -$379K 0.54% 54
2018
Q3 		$1.18M Buy
11,823
+10,114
+592% +$839K 0.9% 43
2018
Q2 		$121K Buy
1,709
+774
+83% +$64.9K 0.1% 103
2018
Q1 		$97K Sell
935
-4,693
-83% -$529K 0.1% 82
2017
Q4 		$567K Buy
+5,628
New +$414K 0.65% 53

Other funds holding ANAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Partner Investment Management's ANAB Position: Q1 2019 in Review

Partner Investment Management sold out of AnaptysBio (ANAB) in Q1 2019, closing a stake of 6,731 shares — an estimated $429K sold.

Partner Investment Management first reported a position in ANAB in Q4 2017 and held it in 5 quarters. The position peaked at $1.18M in Q3 2018. 129 funds tracked by Wall St. Rank hold ANAB as of Q1 2019.

  • Partner Investment Management reported no remaining AnaptysBio position as of Q1 2019 after selling out during the quarter.
  • Partner Investment Management sold 6,731 AnaptysBio shares in Q1 2019, an estimated $429K.
  • Partner Investment Management first reported a position in AnaptysBio in Q4 2017 and held it in 5 quarters.
  • Partner Investment Management's AnaptysBio position peaked at $1.18M in Q3 2018.
  • 129 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2019.

Based on Partner Investment Management's 13F filing for Q1 2019, filed 15 May 2019.